Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeTax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Exozymes (EXOZ) Income from Continuing Operations (2023 - 2024)

Exozymes (EXOZ) has disclosed Income from Continuing Operations for 2 consecutive years, with 1838117.0 as the latest value for Q4 2024.

  • Quarterly Income from Continuing Operations fell 74.02% to 1838117.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was 5863477.0 through Dec 2024, changed N/A year-over-year, with the annual reading at 9158734.0 for FY2025, 56.26% down from the prior year.
  • Income from Continuing Operations for Q4 2024 was 1838117.0 at Exozymes, down from 1656372.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 520596.0 in Q3 2023, with the low at 1838117.0 in Q4 2024.